Apart of an increased residence time at the centromere during the G1/S phase of the cell cycle, 41
little is known about the dynamic regulation of CENP-B at the centromere (Hemmerich et al., 2008) . 42 In the present study we investigated the role of SUMO (Small Ubiquitin Modifier) modification on 43 CENP-B stability at centromeres. We demonstrate that CENP-B could be SUMOylated in vitro on 44 several lysine (K) residues, with K402 being the major SUMO modified residue. CENP-B K402 45 modification influenced CENP-B turnover at centromeres through a proteasome-dependent 46 1 (hereafter called RNF4). dynamics at centromeres, and consequently on the centromeres activity itself. To detect lysine 10 residues present in putative SUMOylation consensus sites we analyzed in silico the human CENP-B 11 sequence using the JASSA (Joint Analyzer of SUMOylation Site and SIMs) software (Beauclair et al., 12 2015) . Four potential SUMOylation sites were found, three of which (K28, K58, K76) associated with 13 the N-terminal DNA binding (DBD) domain and one (K402) present in the core of the protein (Fig.  14  1A) . To determine if any of the 4 K residues were acceptor sites for CENP-B SUMOylation, point 15 mutations were introduced in the CENP-B nucleotide sequence to produce CENP-B proteins mutated 16 on each K individually or in combination (Fig. 1B) . We did not use the usual modification K>R but 17 rather K>G (or P) because due to the high GC content of the CENP-B nucleotide sequence (over 65%) 18 some SUMOylation site-associated Ks where not in a proper environment to design oligonucleotides 19 suitable to perform K>R site mutagenesis. In vitro SUMOylation assays showed that CENP-Bwt and 20 CENP-B_3K were SUMOylated to comparable levels to that of the positive control promyelocytic 21 leukemia (PML) protein (Fig. 1C , compare lanes 4, 6, and 10). In contrast, CENP-B_4K had a 22 significantly reduced SUMOylation pattern (Fig. 1C, lane 8 ). This result confirms that CENP-B can be 23 SUMOylated and demonstrates that K402 is the main SUMOylated lysine. Quantitation of unmodified 24 forms of CENP-Bwt and CENP-B_3K using the LI-COR Infrared Fluorescent Imaging System suggested 25 that other K in the DBD could be SUMO modified (Fig. S1A ). We performed additional assays using a 26 CENP-B protein deleted of the first 129 aa constituting the DBD domain (CENP-B∆DBD; (Yoda et al., 27 1992; Tanaka et al., 2005b) or the same protein with the additional mutation of K402 (CENP-28 B∆DBD_K402G) ( Fig. 1D and S1B). Compared to CENP-Bwt, CENP-B∆DBD SUMO signal was 29 substantially decreased (compare lanes 2 and 6), and CENP-B∆DBD_K402G lost almost the entire 30 SUMOylation signal (compare lanes 2 and 4). This confirms that although K402 contributes for the 31 majority of the CENP-B SUMO signal, several lysine residues in the DBD are probably also substrates 32 for SUMO modifications. To demonstrate that CENP-B could be covalently linked to SUMO in vivo, we 33 performed denaturing HIS-pull down assays from cells ectopically expressing CENP-Bwt and 6xHIS-34 tagged SUMO-1. Although the HA tag has, on its own and unspecifically, an affinity for the Ni-NTA 35 agarose resin, the result clearly showed that a high molecular weight extra CENP-B band was 36 reproducibly detected when CENP-B was co-expressed with 6xHIS-SUMO-1 (Fig. 1E ). This result 37
indicates that CENP-B could be covalently linked to SUMO in cells, although this is likely to represent 38 a minute part of the CENP-B protein.
Altogether, these data demonstrate that CENP-B is a substrate 39 for SUMOylation, which validates the previously published SUMO'omics data. 40 41
SUMO pathway but not K402 is essential for CENP-B targeting to the centromere 42
A previous study showed the exchange of CENP-B at centromeres to be highly dynamic during 43 the G1-S phases of the cell cycle (Hemmerich et al., 2008) . To determine if SUMOylation was involved 44 in CENP-B targeting to centromeres, we analyzed the accumulation of ectopically expressed HA-45
CENP-Bwt at centromeres in cells depleted of Ubc9, the only known mammalian E2 SUMO 46 conjugating enzyme, by RNA interference ( Fig. 2A and B) . Depletion of Ubc9 did not affect HA-CENP-1 B expression ( Fig. 2A) Fig. 2Ci and ii) . Only the CENP-B∆DBD showed a complete absence of 9 CENP-B at centromeres (Fig. 2Ciii) , as expected from previous studies (Pluta et al., 1992) and 10 seemingly easily explained by its inability to bind to CENP-B boxes. However, and strikingly, the 11 additional mutation of K402 in the CENP-B∆DBD background restored to some extent a CENP-B 12 centromeric signal ( Fig. 2Civ and Fig. 3Bv To determine if CENP-B SUMOylation influenced its stability at centromeres the accumulation of 32 ectopically expressed CENP-Bwt, CENP-B∆DBD, and CENP-B∆DBD_K402G were measured in HeLa 33 cells in the presence or not of the proteasome inhibitor MG132 (Fig. 3A) . In the presence of MG132, 34
CENP-Bwt showed a clear aggregation pattern with most of the CENP-B signal co-localized with or 35 juxtaposed to centromeres. Some CENP-B aggregates were also visible not-colocalizing with 36 centromeres possibly highlighting neo-synthesized CENP-B not incorporated in centromeres and not 37 degraded ( Fig. 3Bi and ii left) . Overall, the addition of MG132 led to an increase in the average size of 38 CENP-B spots ( Fig. 3Bi and ii middle (ROI)) represented by a number of pixels/spot that shifted 39 towards higher values ( Fig. 3B up-right) . CENP-B∆DBD and CENP-B∆DBD_K402G lack the DBD 40 domain and are not able to bind the CENP-B boxes of the alphoid sequences. Accordingly, no CENP-41 A co-localization was observed with the diffuse CENP-B∆DBD nucleoplasmic signal in the absence of 42 MG132 (Fig. 3Biii left, and middle) . The addition of MG132 partially restored CENP-B∆DBD co-43 localization with CENP-A (Fig. 3Biv left, and middle (ROI)) and enabled the detection of spots with 44 low values of pixels/spot ( Fig. 3B middle-right) . Strikingly, the sole mutation of K402 within the 45 CENP-B∆DBD background was enough to partially restore CENP-B signal at centromeres, a 46 phenotype that was amplified in the presence of MG132 (Fig. 3Bv and vi left, and middle (ROI) ). 1
Similarly to CENP-Bwt, the number of pixels/spot shifted towards higher values in the presence of 2 MG132 (Fig. 3B down-right) . Ectopically expressed CENP-Bwt showed very large aggregates in the 3 presence of MG132 most of them co-localized/juxtaposed to CENP-A signal. The enlargement of the 4 CENP-B signal could be due to its oligomerization and/or to a modification of the shape of the CENP-5 B box containing, but CENP-A deficient, centromere regions not necessarily detectable by the sole 6 labeling of CENP-A. To verify the latter, immuno-FISH was performed to detect CENP-B and 7
centromeres using a probe labelling as many centromere sequences as possible (Fig. 3C) . Data 8 showed that the size of the signal labelled by the probe was not enlarged in cells expressing ectopic 9
CENP-Bwt and treated with MG132. This result does not favor an unwinding of the centromere 10 regions due to the presence of undegraded CENP-B. Overall, the results show that proteasome 11 inhibition induces the aggregation of CENP-B at or in the immediate vicinity of centromeres, which 12 highly suggests a control of CENP-B stability by the proteasome with the contribution of K402. 13 CENP-B∆DBD, and CENP-B∆DBD_K402G lose their capacity to bind to the CENP-B boxes 14 present in the alphoid sequences. However, the C-terminal region of CENP-B is involved in its 15 dimerization at the centromeres. Therefore, CENP-B∆DBD, and CENP-B∆DBD_K402G could be 16 retained at the centromeres in a stochastic manner through the interaction with endogenous CENP-17 B in HeLa cells. If the process of degradation of the mutated CENP-B is faster than its residence time, 18 the centromeric accumulation of the protein by the sole interaction through its C-terminal domain is 19 likely to be too weak to be visualized. In agreement with this hypothesis, CENP-B∆DBD was only 20 visualized localizing with centromeres in cells treated with the proteasome inhibitor MG132 21 (compare Fig. 3Biii and iv). The detection of CENP-B∆DBD_K402G at centromeres, even in the 22 absence of MG132 treatment, suggests that K402 could be involved in the turnover of CENP-B at 23 centromeres in a proteasome-dependent manner. If so, the exchange rate of CENP-B∆DBD_K402G at 24 centromeres would be expected to decrease in comparison to wild-type CENP-B. To test this 25 hypothesis, we performed fluorescent recovery after photobleaching (FRAP) experiments using GFP-26 CENP-Bwt and GFP-CENP-B_K402G (Fig. 3D ). Both GFP-fused proteins were correctly targeted to 27 centromeres ( Fig. S2Ai and (Fig. 4Bi to vi) . Ectopically expressed 1 CENP-Bwt, CENP-B∆DBD, and CENP-B∆DBD_K402G co-localized with SUMO-1 at centromeres in 2 MG132-treated (Fig. 4Cii , iv, vi), but not untreated (Fig. 4Ci , iii, v) cells. Similar data were obtained 3 with SUMO-2/3 (Fig. S3 ). Co-localization of ubiquitin together with CENP-Bwt, CENP-B∆DBD, and 4 CENP-B∆DBD_K402G was also observed at centromeres in MG132-treated cells (Fig. 4D) Fig. 5Ai and ii; Fig. 5B ), but not CENP-A (Fig 5Av) , in a manner that was dependent on 34 the catalytic activity of the RING-finger domain of RNF4 (RNF4DN) (3.5 ± 3.3 %, p = 1.6 10 -6 ) ( Fig. 5Aiii  35 and iv; Fig 5B) . Interestingly, mutation of the RNF4 RING-domain also increased the number of spots 36 of RNF4 co-localizing with CENP-B or CENP-A at centromeres (Fig 5Avi and vii) . Co-transfection of 37 SUMO-1 or SUMO-2 with RNF4wt induced a small but statistically significant increase in cells 38
showing CENP-B depletion (55.8 ± 5.6 %; p = 0.043 for SUMO-1, and 54.2 ± 5.5 %, p = 0.05 for SUMO-39 2; 500 cells counted over 4 experiments) (Fig. 5B ), which suggested a role of SUMOylation in addition 40 to RNF4 in the control of CENP-B stability at centromeres. Co-immunoprecipitation assays using 41 ectopically expressed proteins highlighted an interaction between CENP-B and RNF4 (Fig. 5C ). The 42 interaction was likely dependent on SUMOylation because the addition of the SUMO proteases 43 inhibitor N-ethylmaleimide (NEM) was required to maintain this interaction whenever RNF4 (Fig.  44 5D, two upper gels compare lanes 4 and 5, and 6 and 7) or CENP-B (Fig 5E, upper gel, compare lanes  45 4 and 5, and 6 and 7) was immunoprecipitated. Addition of NEM also enabled the detection of high 46 molecular weight (HMW) signals detected by the FLAG antibody (Fig. 5D , long exposure membrane). 1
Stripping and reprobing the membranes enabled the detection of SUMOs ( Fig. 5D and 5E, two middle 2 gels) and ubiquitin ( enables the formation of the kinetochore structure to which microtubules attach during mitosis. 1 CENP-B is one of the first proteins described as a major constituent of the centromere present 2 during the entire cell cycle (Earnshaw These data suggested a role for K402 in the combined SUMO/ubiquitin/proteasome-dependent 26 turnover of CENP-B at centromeres. Our FRAP data indeed showed that K402 mutation affected the 27 mobility of centromere-associated CENP-B, unlike nucleoplasmic CENP-B, and was therefore 28 implicated in CENP-B dynamics at centromeres. 29
A previous study showed that during interphase, CENPs could be exchanged at the 30 centromeres, revealing unexpectedly complex and dynamic changes within the centromere 31 throughout cell cycle progression (Hemmerich et al., 2008) . Two different CENP-B populations were 32 described with drastically different centromere residence times based on the G1/S or G2 cell cycle 33 stages. During the former, CENP-B is very dynamic with a rapid exchange rate, whereas in G2 CENP-34 B is stably bound to the centromere. If CENP-B K402-dependent centromeric turnover is linked to 35 the process of SUMOylation/ubiquitination and proteasome degradation, then both SUMOs and 36 ubiquitin should be detected at centromeres in some specific experimental conditions. This was 37 indeed the case for SUMOs in a subset of cells in interphase when MG132 treatment was applied for 38 a short period of time. This was much more obvious when MG132 was applied to cells ectopically in vitro experiments showed that although the SUMOylation of CENP-B was greatly diminished in 1 both proteins, some SUMOylation remained, suggesting the possibility of other SUMOylable lysines, 2 at least in vitro. All these data are summarized in a working model outlined in Figure 7D . CENP-B mutants, and RNF4DN (C132/135S)-expressing plasmids were obtained by site-directed 1 mutagenesis using the QuickChange® kit (Agilent). CENP-B K28, K58, K76 and K402 were mutated 2 in P28, G58, G76 and G402 respectively. Multiple lysine-mutated CENP-B sequences were obtained 3 by sequential site-directed mutagenesis. 4
PET28b-6xHis-CENP-Bwt plasmid was first constructed by insertion of the CENP-Bwt ORF. PET28b-5 6xHis-CENP-B_Kmut plasmids were then obtained either by sub-cloning from the pcDNA-CENP-6
B_Kmut plasmids or by site-directed mutagenesis. PET28b-6xHis-FLAG-CENP-Bwt and pET28b-7 6xHis-FLAG-CENP-B_Kmut plasmids were constructed by in frame insertion of a 69nt fragment 8 containing the 3x-Flag and isolated from the p3xFLAG-CMV10 plasmid, between the 6xHis and the 9 ATG of the CENP-Bwt and mutant ORFs or by sub-cloning. PET28b-6xHis-FLAG-PML was obtained 10 by sub-cloning of PML cDNA in the pET28b-6xHis-FLAG vector. 11 pLVX-6xHis-SUMO-1 vector was kindly provided by Dr Ben Hale (Institute of Medical Virology, 12
University of Zürich). GuHCL, 100mM  22 Na2HPO4, 100mM NaH2PO4, 10mM Tris/HCl pH 8.0, 10mM imidazole, ß-mercaptoethanol 5mM, 23 benzonase 250U/mL). After 20min lysis on ice, the solution was sonicated using a probe-sonicator. 24
The debris were pelleted and the supernatant was transferred in a new tube before adding 60 µl of 25
Ni-NTA agarose resin (Quiagen) pre-equilibrated with denaturing sample buffer, and incubated by 26 rotation for at least 16 hours at 4°C. Beads were spun out of suspension and the resin was transferred 27 into a new tube. The resin was washed once with denaturing sample buffer, then twice with 28 denaturing pH 8.0 wash buffer (8M urea, 100mM Na2HPO4, 100 mM NaH2PO4, 10mM Tris/HCl pH 29 8.0, 10mM imidazole, ß-mercaptoethanol 5mM), then twice with denaturing pH 6.3 wash buffer (8M 30 urea, 100mM Na2HPO4, 100 mM NaH2PO4, 10mM Tris/HCl pH 6.3, 10mM imidazole, ß-31 mercaptoethanol 5mM Bwt, GFP-CENP-B_K402G, GFP-CENP-B∆DBD, or GFP-CENP-B∆DBD_K402G using effectene reagent 36 (Qiagen). Bleaching was performed with the 458, 488 and 514 nm lines of an argon laser (set to 37 100%) and the 561 nm line of a DPS 561 laser. Five pre-bleach images were collected, followed with 38 a 145 ms bleach pulse on a 3 μm diameter spot. Images were collected every 393ms during 120 sec 39 after simultaneous bleaching of two centromeres per nucleus. Images were acquired with the 488 40 nm line of the argon laser (set to 1%). Loss of fluorescence due to acquisition was calculated using 41 total fluorescence of the cell, and pre-bleach intensity as reference. . C., Sullivan, K. F., Machlin, P. S., Cooke, C. A., Kaiser, D. A., Pollard, T. D., Rothfield, N. F. and , I., Fu, H., Nakano, M., Kim, J.-H., Miga, K. H., Liskovykh, M., Earnshaw, W. C., Masumoto, H. 
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